We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.62B
AUM Growth
–
Cap. Flow
+$4.56B
Cap. Flow %
98.7%
Top 10 Hldgs %
48.03%
Holding
637
New
637
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$400M
2
AAPL icon
Apple
AAPL
+$352M
3
MSFT icon
Microsoft
MSFT
+$326M
4
AMZN icon
Amazon
AMZN
+$218M
5
META icon
Meta Platforms (Facebook)
META
+$195M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 45.41%
2 Consumer Discretionary 17.29%
3 Communication Services 14.35%
4 Healthcare 6.6%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLDB icon
626
Solid Biosciences
SLDB
$836M
$3.36K ﹤0.01%
+839
New +$4.61K
STRO icon
627
Sutro Biopharma
STRO
$411M
$3.19K ﹤0.01%
+173
New +$5.28K
TSVT
628
DELISTED
2seventy bio
TSVT
$3.18K ﹤0.01%
+1,083
New +$4.44K
TCRX icon
629
TScan Therapeutics
TCRX
$49.4M
$3.13K ﹤0.01%
+1,031
New +$4.67K
BMEA icon
630
Biomea Fusion
BMEA
$88.2M
$3.04K ﹤0.01%
+784
New +$6.25K
PEPG icon
631
PepGen
PEPG
$123M
$2.59K ﹤0.01%
+684
New +$4.26K
ENTA icon
632
Enanta Pharmaceuticals
ENTA
$378M
$2.56K ﹤0.01%
+445
New +$4.27K
CLYM
633
Climb Bio
CLYM
$692M
$2.54K ﹤0.01%
+1,412
New +$5.11K
EDIT icon
634
Editas Medicine
EDIT
$413M
$2.32K ﹤0.01%
+1,830
New +$4.66K
OKUR
635
OnKure Therapeutics
OKUR
$162M
$2.29K ﹤0.01%
+266
New +$4.03K
PYXS icon
636
Pyxis Oncology
PYXS
$182M
$1.95K ﹤0.01%
+1,249
New +$3.6K
QTTB icon
637
Q32 Bio
QTTB
$462M
$881 ﹤0.01%
+256
New +$8.08K
22 23 24 25
26

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for GF Fund Management, which disclosed 637 positions worth $4.62B. Its ten largest holdings account for 48% of the portfolio.

Its largest position is NVIDIA: 2,904,119 shares worth $390M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q4 2024 buy was NVIDIA: 2,904,119 shares worth $390M.
  • GF Fund Management's ten largest holdings make up 48% of its $4.62B portfolio in Q4 2024.
  • GF Fund Management disclosed 637 positions in Q4 2024, its first 13F filing on record.

Based on GF Fund Management's 13F filing for Q4 2024, filed 19 Feb 2025.